Skip to main content

Movano, Inc. (MOVE)

NASDAQ: MOVE · Delayed Price · USD
-0.02 (-0.78%)
After-hours:Oct 21, 2021 4:00 PM EDT
0.08 (2.77%)
At close: Oct 21, 4:00 PM
Market Cap101.59M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out32.02M
EPS (ttm)-2.17
PE Ration/a
Forward PEn/a
Ex-Dividend Daten/a
Previous Close3.04
Day's Range3.06 - 3.15
52-Week Range2.78 - 7.45
Price Targetn/a
Est. Earnings DateNov 11, 2021

About MOVE

Movano Inc., a technology company, develops a smart wearable and continuous glucose monitoring device. Its device enables individuals and their healthcare partners to measure and manage their health conditions. Movano Inc. was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. The company was incorporated in 2018 and is based in Pleasanton, California.

IndustryInternet Software & Services (discontinued effective close of September 28, 2018)
IPO DateMar 23, 2021
Stock ExchangeNASDAQ
Ticker SymbolMOVE
Full Company Profile

Financial Performance

Financial Statements


Movano Inc. to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021

PLEASANTON, Calif., Oct. 14, 2021 /PRNewswire/ --  Movano Inc.

1 week ago - PRNewsWire

Clean Power Capital Graduates Listing to the NEO Exchange

TORONTO--(BUSINESS WIRE)---- $MOVE #NEOExchange--Clean Power Capital Corp. (NEO:MOVE), previously listed on the Canadian Securities Exchange, has graduated to the NEO Exchange.

5 months ago - Business Wire

Movano Inc. Appoints Medtech Industry Veteran John Mastrototaro, PhD, as CEO

As the pioneer of the first FDA-approved continuous glucose monitor, Dr. Mastrototaro will be integral in advancing the development and regulatory process of the Company's glucose and blood pressure mon...

6 months ago - Accesswire

Movano Inc. Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option

PLEASANTON, CA / ACCESSWIRE /  March 25, 2021 / Movano Inc. (NASDAQ:MOVE), a health technology company designing devices that empower individuals to optimize their health in order to prevent and better ...

6 months ago - Accesswire

Glucose monitoring device developer Movano files for a $41 million IPO

Movano, which is developing a wearable device for measuring glucose, blood pressure, and heart rate, filed on Tuesday with the SEC to raise up to $41 million in an initial public offering.

8 months ago - NASDAQ

Movano IPO Registration Document (S-1)

Movano, Inc. has filed to go public with an IPO on the NASDAQ.

8 months ago - SEC